| Financial Year |
March 31 2023 |
| Monetary Funds |
1,840,860,133.30 |
| Held-for-trading Financial Assets |
19,968,520.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,727,181,495.91 |
| Advances to Suppliers |
29,646,831.65 |
| Other Receivables |
28,913,598.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,330,528.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,666,036.25 |
| Total Current Assets |
3,755,567,144.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
178,304,670.56 |
| Investment Properties |
136,892,791.77 |
| Fixed Assetes |
305,128,413.43 |
| Under-construction Projects |
2,232,722.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,560,762.02 |
| R&D expenses |
1,682,663.76 |
| Goodwill |
617,022,998.87 |
| Long-Term Deferred and Prepaid Expenses |
38,566,042.91 |
| Deferred Income Tax Assets |
46,083,888.71 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,527,172,135.71 |
| Total Assets |
5,282,739,280.58 |
| Short-Term Loans |
103,244,161.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
83,495,310.15 |
| Accounts Received In Advance |
5,249,076.70 |
| Employee Compensation Payable |
662,070,342.44 |
| Taxes Payable |
90,232,273.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
129,926,842.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
95,828,561.88 |
| Other Current Liabilities |
59,024,622.14 |
| Sub-Total of Current Liabilities |
1,264,300,971.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
950,448.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,650,118.76 |
| Total Liabilities |
1,302,951,089.88 |
| Paid-In Capital(Or Share Stock) |
591,664,848.00 |
| Capital Surplus |
1,417,246,133.87 |
| Surplus Reserve |
114,781,480.32 |
| LESS:Treasury Stock |
105,676,479.30 |
| Undistributed Profits |
1,886,496,714.97 |
| Minority Stockholder's Interest |
44,653,015.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,935,135,175.61 |
| Owner's Equity（Stockholder's Equity） |
3,979,788,190.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,282,739,280.58 |
